Neurones S.A. (EPA:NRO)
France · Delayed Price · Currency is EUR 38.15
-0.30 (-0.78%)
Jul 31, 2026, 5:35 PM CET
Neurones Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 911 | 1,047 | 1,067 | 1,062 | 951 | 921 | |
Market Cap Growth | -13.35% | -1.88% | 0.46% | 11.71% | 3.26% | 62.46% |
Enterprise Value | 681.54 | 807.88 | 840.47 | 862.26 | 759.24 | 732.31 |
Last Close Price | 38.15 | 43.05 | 43.95 | 43.75 | 39.25 | 38.00 |
PE Ratio | 17.83 | 20.12 | 20.35 | 21.55 | 21.57 | 24.36 |
Forward PE | 16.39 | 18.89 | 21.08 | 20.73 | 19.54 | 22.28 |
PEG Ratio | - | 1.45 | 1.45 | 1.45 | 1.45 | 1.45 |
PS Ratio | 1.06 | 1.22 | 1.32 | 1.43 | 1.43 | 1.59 |
PB Ratio | 1.96 | 2.62 | 2.82 | 2.99 | 2.88 | 2.96 |
P/TBV Ratio | 2.76 | 3.11 | 3.35 | 3.53 | 3.35 | 3.47 |
P/FCF Ratio | 14.96 | 14.68 | 12.64 | 14.73 | 17.30 | 14.27 |
P/OCF Ratio | 12.77 | 14.68 | 12.64 | 14.73 | 17.30 | 14.27 |
EV/Sales Ratio | 0.80 | 0.94 | 1.04 | 1.16 | 1.14 | 1.26 |
EV/EBITDA Ratio | 12.95 | 8.49 | 8.79 | 9.31 | 8.49 | 9.60 |
EV/EBIT Ratio | 20.61 | 10.69 | 10.79 | 11.37 | 10.42 | 11.89 |
EV/FCF Ratio | 11.20 | 11.33 | 9.96 | 11.96 | 13.81 | 11.35 |
Debt / Equity Ratio | 0.06 | 0.06 | 0.08 | 0.09 | 0.07 | 0.08 |
Debt / EBITDA Ratio | 0.70 | 0.39 | 0.44 | 0.48 | 0.40 | 0.47 |
Debt / FCF Ratio | 0.52 | 0.52 | 0.50 | 0.61 | 0.65 | 0.55 |
Net Debt / Equity Ratio | -0.76 | -0.76 | -0.75 | -0.71 | -0.71 | -0.74 |
Net Debt / EBITDA Ratio | -5.77 | -3.19 | -2.98 | -2.74 | -2.64 | -3.01 |
Net Debt / FCF Ratio | -4.26 | -4.26 | -3.37 | -3.52 | -4.30 | -3.56 |
Asset Turnover | 1.16 | 1.16 | 1.16 | 1.15 | 1.12 | 1.04 |
Quick Ratio | 2.41 | 2.41 | 2.31 | 2.36 | 2.41 | 2.50 |
Current Ratio | 2.43 | 2.43 | 2.33 | 2.38 | 2.45 | 2.51 |
Return on Equity (ROE) | 13.73% | 13.73% | 14.95% | 14.92% | 14.21% | 12.06% |
Return on Assets (ROA) | 3.26% | 7.45% | 7.98% | 8.52% | 8.75% | 7.66% |
Return on Invested Capital (ROIC) | 14.93% | 35.13% | 36.34% | 37.29% | 39.49% | 34.14% |
Return on Capital Employed (ROCE) | 6.81% | 15.55% | 16.94% | 17.72% | 18.40% | 15.96% |
Earnings Yield | 5.72% | 4.97% | 4.91% | 4.64% | 4.64% | 4.11% |
FCF Yield | 6.68% | 6.81% | 7.91% | 6.79% | 5.78% | 7.01% |
Dividend Yield | 3.67% | 3.02% | 2.73% | 2.51% | 2.55% | 5.26% |
Payout Ratio | 60.73% | 60.73% | 55.42% | 53.93% | 54.75% | 128.42% |
Buyback Yield / Dilution | -0.13% | -0.13% | -0.14% | -0.10% | -0.18% | 0.13% |
Total Shareholder Return | 3.54% | 2.89% | 2.59% | 2.42% | 2.37% | 5.39% |